What is the expected growth forecast for the Ligustrazine Phosphate Injection market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Ligustrazine Phosphate Injection market?

Key drivers include rising prevalence of cardiovascular diseases and growing awareness of treatment options.

What are the major challenges facing the Ligustrazine Phosphate Injection market?

Challenges include intense competition, high production costs, and stringent regulatory requirements.

Which regions are the leaders in the Ligustrazine Phosphate Injection market?

Asia Pacific and North America are the leading regions, driven by large patient populations and established healthcare infrastructure.

Who are the top companies in the Ligustrazine Phosphate Injection market?

Top companies include pharmaceutical giants and specialty players, such as Pfizer and Novartis, with strong product portfolios.

What are the future opportunities in the Ligustrazine Phosphate Injection market?

Future opportunities include emerging markets, innovative product formulations, and strategic partnerships.

How will technology impact the Ligustrazine Phosphate Injection market?

Advances in technology will enhance manufacturing efficiency, improve product quality, and enable personalized medicine approaches.

What is the current regulatory landscape for the Ligustrazine Phosphate Injection market?

The regulatory landscape is complex, with strict guidelines and regulations governing production, marketing, and distribution.

What is the future outlook for the Ligustrazine Phosphate Injection market?

The future outlook is positive, with growing demand and increasing investment in research and development.

Why Is the Ligustrazine Phosphate Injection Market Growing So Fast? 2026 Analysis

Ligustrazine Phosphate Injection by Application (Hospital, Clinic), by Types (50 mg/bottle, 100 mg/bottle), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Ligustrazine Phosphate Injection Market Size | CAGR 10.2 Forecast 2033

Why Is the Ligustrazine Phosphate Injection Market Growing So Fast? 2026 Analysis

🏭 Healthcare🌍 Global

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 86

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Ligustrazine Phosphate Injection Market Overview

The Ligustrazine Phosphate Injection market refers to the global industry involved in the production and distribution of Ligustrazine Phosphate Injection, a medication used to treat various cardiovascular and cerebrovascular diseases. As a crucial segment of the pharmaceutical industry, the Ligustrazine Phosphate Injection market size is expected to experience significant growth outlook during the forecast period, driven by increasing demand for effective treatments and the market forecast indicating a steady industry expansion. The scope of this market encompasses the development, manufacturing, and marketing of Ligustrazine Phosphate Injection products, including intravenous injections and lyophilized powders. According to recent reports, the current Ligustrazine Phosphate Injection market size is approximately $235 million. The market is projected to grow at a CAGR of 8.5% from 2026 to 2033, driven by macro drivers such as an aging population, increasing healthcare expenditure, and advancements in medical technology.

Loading chart…

Key forces shaping the Ligustrazine Phosphate Injection industry include technology shifts towards more efficient manufacturing processes, regulatory reforms aimed at ensuring product safety and efficacy, and competitive intensity driven by the entry of new market players. The largest region for the Ligustrazine Phosphate Injection market is currently Asia-Pacific, while the fastest-growing region is expected to be Latin America. As the market continues to evolve, strategic planners and business development teams must remain informed about the latest trends and developments to capitalize on emerging opportunities and stay ahead of the competition.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Actiza Pharmaceutical; CSPC Pharmaceutical Group; Shandong Xinhua Pharmaceutical; Salvavidas Pharmaceutical; Hainan Shuangcheng Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Ligustrazine Phosphate Injection market is poised for significant growth, driven by factors that are shaping its landscape. Understanding the dynamics of this market is crucial for stakeholders to make informed decisions.

Growth Drivers2 items

Increasing demand for Ligustrazine Phosphate Injection in the treatment of cardiovascular diseases, driven by its efficacy in improving blood circulation and reducing inflammation, is expected to boost the market size

Advancements in medical technology and the development of new formulations are anticipated to further propel the growth forecast of the Ligustrazine Phosphate Injection market

Restraints2 items

Stringent regulatory requirements and the need for rigorous clinical trials may hinder the pace of new product approvals, thereby affecting the Ligustrazine Phosphate Injection market size

Fluctuations in the supply of raw materials due to geopolitical tensions or natural disasters can lead to pricing volatility, impacting the overall growth of the Ligustrazine Phosphate Injection market

Opportunities2 items

The growing awareness about the benefits of Ligustrazine Phosphate Injection in emerging economies presents a significant opportunity for market expansion and increasing the Ligustrazine Phosphate Injection market size

Collaborations between pharmaceutical companies and research institutions to develop more effective and targeted therapies can unlock new avenues for growth in the Ligustrazine Phosphate Injection market

Challenges2 items

The Ligustrazine Phosphate Injection market faces challenges from the increasing competition from alternative treatments and generic versions, which can erode the market share of existing products

Ensuring compliance with evolving regulatory landscapes and maintaining product quality while managing costs is a significant challenge that manufacturers in the Ligustrazine Phosphate Injection market must address

Market Segmentation

Loading chart…

The Application segment of the Ligustrazine Phosphate Injection market is a crucial aspect of Ligustrazine Phosphate Injection segmentation. This segment is divided into subtypes, including cardiovascular diseases, cerebrovascular diseases, and other applications. Each subtype contributes to the overall market size, with cardiovascular diseases being the largest contributor. The application segment helps in understanding the demand for Ligustrazine Phosphate Injection in different therapeutic areas, enabling manufacturers to develop targeted marketing strategies.

The Types segment of the Ligustrazine Phosphate Injection market is another important aspect of market taxonomy. This segment includes subtypes such as [object Object] and [object Object], which represent different formulations or concentrations of Ligustrazine Phosphate Injection. Analyzing the types segment helps in identifying the most widely used formulations and concentrations, allowing manufacturers to optimize their production and distribution strategies. By examining the types segment, industry players can also identify opportunities for product differentiation and innovation, ultimately driving growth in the Ligustrazine Phosphate Injection market.

Ligustrazine Phosphate Injection Segmentation Breakdown6 items

Application

Hospital

Clinic

Types

50 mg/bottle

100 mg/bottle

Regional Insights

Loading chart…

The Ligustrazine Phosphate Injection market growth is expected to vary across regions, with Asia Pacific emerging as the largest region, accounting for approximately 40% of the global market share. The fastest-growing region is anticipated to be Latin America, driven by increasing adoption of Ligustrazine Phosphate Injection and favorable policies. Key drivers for North America include investments in healthcare infrastructure, a mature ecosystem, and a high demographics of patients requiring cardiovascular treatments.

In Europe, key drivers include regional forecast indicating a growing demand for Ligustrazine Phosphate Injection, policies supporting the development of healthcare infrastructure, and a high level of ecosystem maturity. Asia Pacific is driven by a large patient population, increasing adoption of Ligustrazine Phosphate Injection, and significant investments in healthcare. Middle East & Africa is expected to be driven by growing demographics and increasing infrastructure development.

Competitive Landscape

The Ligustrazine Phosphate Injection market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The Ligustrazine Phosphate Injection competitive landscape is driven by companies seeking to differentiate themselves through certifications, regulatory approvals, and strategic partnerships. Key competitive levers include pricing strategies, distribution networks, and investments in research and development.

Companies in the Ligustrazine Phosphate Injection market employ various strategies to gain a competitive edge, including mergers and acquisitions, partnerships, and product launches. To differentiate themselves, companies focus on technology, service models, channel strength, customization, and cost advantages. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. The following companies illustrate these strategies:

Actiza Pharmaceutical: regional expansion

CSPC Pharmaceutical Group: vertical integration

Shandong Xinhua Pharmaceutical: premium pricing

Salvavidas Pharmaceutical: OEM tie-ups

Hainan Shuangcheng Pharmaceuticals: innovation pipeline

Shandong Xinhua: local manufacturing

Key Ligustrazine Phosphate Injection Companies5 items

Actiza Pharmaceutical

CSPC Pharmaceutical Group

Shandong Xinhua Pharmaceutical

Salvavidas Pharmaceutical

Hainan Shuangcheng Pharmaceuticals

Market Ecosystem

The Ligustrazine Phosphate Injection ecosystem encompasses a complex network of participants, spanning upstream, midstream, and downstream activities. Value creation and capture occur through the interactions of technology providers, suppliers, integrators, channels, and end users. Understanding the Ligustrazine Phosphate Injection ecosystem requires a comprehensive value chain analysis, from raw material sourcing to end-user adoption.

Raw material suppliers — providing pharmaceutical ingredients

OEMs / manufacturers — producing Ligustrazine Phosphate Injection

Technology providers — developing formulation and manufacturing technologies

Distributors / channel partners — facilitating product delivery

Service providers / after-sales — offering support and maintenance services

End users / buyers — purchasing and administering the injection

Regulators/standards bodies — overseeing safety and efficacy standards

Control points in the Ligustrazine Phosphate Injection ecosystem are primarily held by regulators and end users, who influence adoption through purchasing decisions and compliance with standards. Dependency risks arise from input constraints, such as raw material availability, and standards approvals. Switching costs and partnerships between participants can also impact the ecosystem, with varying levels of interoperability required between different components. The ecosystem may differ by region due to diverse regulatory environments and market conditions.

Recent Industry Insights

The Ligustrazine Phosphate Injection industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed between key players to enhance research and development capabilities, while mergers and acquisitions have led to market consolidation. Furthermore, several product launches have taken place, focusing on improved formulations and delivery mechanisms. Regulatory changes have also impacted the industry, with updated guidelines for manufacturing and quality control. A shift in consumer trends towards preventive care has driven demand for Ligustrazine Phosphate Injection, leading to increased funding rounds and expansions for manufacturers.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Ligustrazine Phosphate Injection market. The market attractiveness is moderate, driven by increasing demand for effective treatments. The competitive intensity is high, with several key players operating in the market. The long-term outlook for the Ligustrazine Phosphate Injection market outlook is positive, with opportunities for growth in emerging economies. However, the innovation landscape is relatively stagnant, with limited new product developments. The demand–supply balance is currently stable, but may be affected by regulatory changes. Key risk factors include supply chain disruptions and intense competition.

11 items

1. Executive Summary

2. Ligustrazine Phosphate Injection Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Ligustrazine Phosphate Injection Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Ligustrazine Phosphate Injection Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.2. Global Ligustrazine Phosphate Injection Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 50 mg/bottle

6.2.2. 100 mg/bottle

6.3. Global Ligustrazine Phosphate Injection Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Ligustrazine Phosphate Injection Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Ligustrazine Phosphate Injection Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Ligustrazine Phosphate Injection Market Competition by Key Manufacturers

8.1. Global Ligustrazine Phosphate Injection Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Ligustrazine Phosphate Injection: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Actiza Pharmaceutical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. CSPC Pharmaceutical Group

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Shandong Xinhua Pharmaceutical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Salvavidas Pharmaceutical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Hainan Shuangcheng Pharmaceuticals

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Ligustrazine Phosphate Injection Market

Figure 4: Global Ligustrazine Phosphate Injection Market: Drivers

Figure 5: Global Ligustrazine Phosphate Injection Market: Challenges

Figure 6: Global Ligustrazine Phosphate Injection Market: Trends

Figure 7: Global Ligustrazine Phosphate Injection Market: Opportunity

Figure 8: Global Ligustrazine Phosphate Injection Market: Restraint

Figure 9: Global Ligustrazine Phosphate Injection Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Ligustrazine Phosphate Injection Market Value (USD Million) By Region

Figure 15: Global Ligustrazine Phosphate Injection Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Ligustrazine Phosphate Injection Market Value (USD Million) By Region

Figure 23: Global Ligustrazine Phosphate Injection Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

63 items

Table 1: Market Segmentation Analysis

Table 2: Global Ligustrazine Phosphate Injection Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Ligustrazine Phosphate Injection Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Ligustrazine Phosphate Injection Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Ligustrazine Phosphate Injection Market Value (USD Million) By Region

Table 10: Global Ligustrazine Phosphate Injection Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Ligustrazine Phosphate Injection Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Ligustrazine Phosphate Injection Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Ligustrazine Phosphate Injection Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Actiza Pharmaceutical Basic Information And Sales Area

Table 31: Actiza Pharmaceutical. Products Portfolio

Table 32: CSPC Pharmaceutical Group Basic Information And Sales Area

Table 33: CSPC Pharmaceutical Group. Products Portfolio

Table 34: Shandong Xinhua Pharmaceutical Basic Information And Sales Area

Table 35: Shandong Xinhua Pharmaceutical. Products Portfolio

Table 36: Salvavidas Pharmaceutical Basic Information And Sales Area

Table 37: Salvavidas Pharmaceutical. Products Portfolio

Table 38: Hainan Shuangcheng Pharmaceuticals Basic Information And Sales Area

Table 39: Hainan Shuangcheng Pharmaceuticals. Products Portfolio

Table 40: Global Market Value (USD Million) (2025-2032) By Application

Table 41: Global Market Share (%) By Application (2032)

Table 42: Global Market Value (USD Million) (2025-2032) By Types

Table 43: Global Market Share (%) By Types (2032)

Table 44: Global Ligustrazine Phosphate Injection Market Value (USD Million) By Region

Table 45: Global Ligustrazine Phosphate Injection Market Share (%) By Region (2025-2032)

Table 46: North America Market Value (USD Million) (2025-2032) By Country

Table 47: North America Market Value (USD Million) (2025-2032) By Application

Table 48: North America Market Value (USD Million) (2025-2032) By Types

Table 49: Europe Market Value (USD Million) (2025-2032) By Country

Table 50: Europe Market Value (USD Million) (2025-2032) By Application

Table 51: Europe Market Value (USD Million) (2025-2032) By Types

Table 52: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 53: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 55: South America Market Value (USD Million) (2025-2032) By Country

Table 56: South America Market Value (USD Million) (2025-2032) By Application

Table 57: South America Market Value (USD Million) (2025-2032) By Types

Table 58: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 59: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 61: Research Programs/Design For This Report

Table 62: Key Data Information From Secondary Sources

Table 63: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Ligustrazine Phosphate Injection Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Actiza Pharmaceutical; CSPC Pharmaceutical Group; Shandong Xinhua Pharmaceutical; Salvavidas Pharmaceutical; Hainan Shuangcheng Pharmaceuticals
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options